Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Metagenomics Market Snapshot (2023 to 2033)

As per the recent market research conducted by FMI, the global metagenomics market is expected to advance at a CAGR of 6.9% during the forecast period. The valuation in 2023 is expected to be US$ 202.9 million. By 2033, the market value is expected to be US$ 394.2 million.

Key factors that may propel the market growth are:

  • The rising use of metagenomics techniques across varied areas increased government and private sector investment in large-scale sequencing projects.
  • An increase in chronic illness cases, and breakthroughs in sequencing technology.
  • Rapid advances in sequencing methods have enabled humans to get a better grasp of previously undiscovered molecular genetics.
  • Metagenomics is gaining popularity for large-scale genomics applications aimed at determining the taxonomic and functional makeup of microbial communities.
  • The growing use of metagenomics in clinical diagnostics is propelling the metagenomics industry forward.

The COVID-19 pandemic is likely to redirect attention to the growing metagenomics business.

As per an article in Future Science, 2021, pandemic risk calculations use metagenomics to trace the molecular changes in pathogens during their emergence. This could aid in the prediction of hotspots of emergence, populations at risk, and pathogens undergoing genetic evolution. Given the foregoing, the COVID-19 pandemic is projected to have a substantial influence on the metagenomics analysis.

Collaborations between government and business entities are also expected to generate sales opportunities for metagenomics throughout the projected period. For example, in October 2021, the USA Food and Drug Administration, the National Institute of Health, and 15 commercial groups entered a strategic partnership. The idea was to discover gene therapy for 30 million Americans who suffer from uncommon diseases.

Key developments in the market include the advancement of sequencing technologies from shotgun sequencing to high-throughput, next-generation sequencing, and third-generation sequencing. These developments would provide an impetus for favorable growth opportunities for market players in the coming years.

As per the regional analysis, North America is expected to be the dominant market. The market will be driven by increased demand for metagenomic sequencing due to the existence of biotechnological firms, and the rising incidence of chronic illnesses. An increase in the number of human genome research initiatives and the adoption of improved diagnostic procedures are also expected to drive market growth.

Attributes Value
Metagenomics Market Value (2022) US$ 189.2 million
Metagenomics Market Expected Value (2023) US$ 202.9 million
Metagenomics Market Forecast Value (2033) US$ 394.2 million
Metagenomics Market Expected CAGR (2023 to 2033) 6.9%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical CAGR (2017 to 2022) vs Anticipated CAGR Trend Analysis

Metagenomics has been in demand owing to its ability to study every type of microorganism, regardless of whether it can be cultured or not. The ability to study prokaryotes and viruses in the environment through the analysis of their DNA makes metagenomics a powerful method. The capability to identify crucial bioactive compounds, enzymes, and antibiotics make metagenomics a highly reliable method. Owing to its increased usage the anticipated CAGR is expected to be more than the historical CAGR. The historical CAGR for the market was 6.4% and the anticipated CAGR is 6.9%.

  • Short-term (2023 to 2026): Increasing the prevalence of various chronic and infectious diseases such as cancer might surge the adoption of metagenomics for the timely diagnosis of these diseases. The growing adoption of metagenomics in clinical diagnostics is providing an impetus for market growth. Metagenomics assists in disease detection in crops and livestock by exploring the interaction between plants and microbes, which might drive the growth in this niche.
  • Medium-term (2026 to 2029): Rising adoption of metagenomics across diverse fields, and increasing investments by government and private agencies for large-scale sequencing projects might happen during this period. Rapid advancements in sequencing tools have allowed for a greater understanding of molecular genetics which was previously unknown to humans. Metagenomics might also gain immense traction for large-scale genomics applications to study the taxonomic and functional composition of microbial communities.
  • Long-term (2029 to 2033): Growing demand for fuels and biofuels across the world is anticipated to further accelerate the market growth over the assessment period. Metagenomics might become one of the promising research tools for discovering novel enzymes to produce biofuel in an efficient way across industries.

How is Increasing Adoption of Metagenomics in Chronic Disease Diagnosis boosting Sales?

As the global burden of chronic diseases continues to rise, research is conducted to test the potentiality of metagenomics for timely diagnosis. This is anticipated to bolster the growth in the metagenomics market.

Metagenomic diagnostics help predict and manage the treatment of a plethora of diseases. It can be effectively used to discover hidden genetic features that could prove vital in various usages. Key applications are in novel enzymes, bioactive molecules, and genes with better or new biochemical functionalities.

In addition, the growing adoption of diagnostic tests based on metagenomics for the early diagnosis of genetic disorders will further expand the market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Will Growing Efforts for controlling Environmental Toxicology influence Demand?

Metagenomics plays a crucial role in bioremediation, a process that uses naturally occurring or artificially introduced microorganisms to break down environmental pollutants.

Metagenomic approaches reveal useful information about the metagenome of microorganisms, which play a key role in the biogeochemical cycles. These are also used for the detoxification of environmental pollutants using culture-independent molecular techniques.

Targeted metagenomics is used to study the phylogenetic diversity and relative abundance of a particular gene in the environment. The increasing need for preventing and controlling environmental toxicity through bioremediation will therefore create growth opportunities for the market.

Comparative View for Metagenomics Market

Metagenomics Market:

Attributes Metagenomics Market
Anticipated CAGR (2023 to 2033) 6.9%
Market Value (2023) US$ 202.9 million
Growth Factor The surge in chronic illness
Future Opportunities Increased government and private sector investment
Market Trends Advancements in sequencing tools

Health and Medical Microalgae Market:

Attributes Health and Medical Microalgae Market
Anticipated CAGR (2023 to 2033) 6%
Market Value (2023) US$ 725 million
Growth Factor Surging demand for natural ingredients in healthcare
Future Opportunities Increase in consumption of clean-label products
Market Trends Manufacturers focus on consumers who suffer from lifestyle diseases

Algae Omega Market:

Attributes Algae Omega Market
Anticipated CAGR (2023 to 2033) 4%
Market Value (2023) US$ 1,063.4 million
Growth Factor Massive demand for clinical nutrition
Future Opportunities Burgeoning demand for animal feeds
Market Trends Manufacturers lay special emphasis on millennials

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

Regions North America
Country United States of America
CAGR (2023 to 2033) 8%
Region Europe
Country United Kingdom
CAGR (2023 to 2033) 5.8%
Region Asia Pacific
Country China
CAGR (2023 to 2033) 8.6%
Region Asia Pacific
Country Japan
CAGR (2023 to 2033) 5.3%
Region Asia Pacific
Country India
CAGR (2023 to 2033) 6.8%

Will the USA market continue witnessing high demand?

Rising prevalence of chronic diseases fueling the adoption of metagenomic sequencing

The USA is projected to dominate the North American market over the forecast period. Increasing demand for metagenomic sequencing due to the heavy presence of biotechnological companies and the rising prevalence of chronic diseases are expected to drive the market. A surge in the number of human genome research projects and the adoption of better diagnostic techniques might as well propel growth.

Attributes Details
United States of America Market Expected Size (2033) US$ 110.3 million
United States of America Market Absolute Dollar Growth US$ 59.4 million
CAGR % 2017 to 2022 6.2%

The USA is home to some of the leading pharmaceutical and biotech companies in the world. These companies are constantly employing techniques such as metagenomic sequencing for studying the nature and pattern of diseases as well as for developing targeted medicines.

What is the United Kingdom market outlook?

The heavy presence of end-use industries generates demand for metagenomic approaches like shotgun sequencing in the United Kingdom

The United Kingdom market is slated to grow at a robust pace over the forecast period, owing to the presence of leading end-use industries, and the growing popularity of shotgun sequencing. The high prevalence of genetic disorders and the continuous rise in genetic research projects are also expected to surge the growth.

Attributes Details
United Kingdom Market Expected Size (2033) US$ 11.1 million
United Kingdom Market Absolute Dollar Growth US$ 4.8 million
CAGR % 2017 to 2022 8.8%

Increasing efforts by the government and private organizations to make the United Kingdom an advanced genomic healthcare system market. The country is one of the leading players in genetics and genome sequencing and spends billions of dollars on developing new diagnostic tools and drugs for a wide range of diseases.

What is driving the China market?

Increasing investments in gene research triggering growth in China

As per FMI, China is anticipated to lead the metagenomics market across the Asia Pacific excluding the Japan region throughout the forecast period. Growth in the market is driven by increasing demand for genetic sequencing, the prevalence of infectious diseases, and increasing investments in gene research.

Attributes Details
China Market Expected Size (2033) US$ 40.2 million
China Market Absolute Dollar Growth US$ 22.5 million
CAGR % 2017 to 2022 7.3%

Rising investments in the healthcare sector by the government and other organizations are expected to fuel the growth in the market. For instance, in 2017 China launched the world’s largest human genome research project of 100,000 people to document their genetic makeup.

The growing popularity of metagenomics-based advanced gene sequencing techniques across agricultural and pharmaceutical industries is positively impacting growth.

Japan market: Driven by wildlife conservation

The Japanese market is mainly driven by a number of endangered species, some of which are the Asian leopard cat, Blakiston’s fish-owl, brown spotted catshark, etc. The zoologists and wildlife veterinarians in Japan are laying a lot of emphasis on their protection.

Metagenomics plays a key role in their conservation. The DNA sequencing technology of metagenomics allows for the identification of microbiomes among and within the hosts. Incorporating the microbial host and biogeographic variation assists in the forest corridor assessments, which helps in gaining a proper understanding of microbial pathogens. Adoption of these methods would help in protecting endangered species.

Attributes Details
Japan Market Expected Size (2033) US$ 24.9 million
Japan Market Absolute Dollar Growth US$ 10 million
CAGR % 2017 to 2022 5.8%

India: Massive number of diabetic patients to drive growth

India is home to numerous diabetic patients in the world. Based on a survey conducted in December 2022, there are more than 74 million adults who suffer from diabetes. This is to say that 1 in 6 adults suffer from diabetes.

Attributes Details
India Market Expected Size (2033) US$ 20.9 million
India Market Absolute Dollar Growth US$ 10.1 million
CAGR % 2017 to 2022 7.4%

The metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in type 2 diabetes. Healthcare has recently suggested a functional model for the development of autoimmunity for type 1 diabetes. These developments are expected to surge the demand for metagenomics in India.

Segmentation Insights

Segment Product Type
Attributes Library Preparation Kits
CAGR % 2017 to 2022 6.3%
CAGR % 2023 to 2033 7.2%
Segment Application
Attributes Clinical Diagnostics
CAGR % 2017 to 2022 6.8%
CAGR % 2023 to 2033 8.3%

Why is the demand for library preparation kits rising?

Sales of library preparation kits to rise at robust pa ace as gene sequencing gains centerstage

As per FMI, sales in the library preparation kits segment accounted for a share of 42.0% in 2022.

DNA and RNA sequencing practices are gaining traction owing to their ability to provide valuable data about gene sequences in a small duration of time. The data generated through gene sequencing is then analyzed and used by clinicians, scientists, and researchers across various verticals such as agriculture, forensics, etc.

Library preparation kits provide efficient and quick extraction of gene segments which are then used for analysis. Moreover, advancements in technology are encouraging manufacturers to launch novel products that reduce error and stress while improving accuracy.

Which is the leading application of metagenomics?

Clinical diagnostics to remain a key application area for metagenomics

By application, demand in the clinical diagnostics and bioremediation segments is expected to remain high over the forecast period. During the last few decades, metagenomics has gained immense traction across the healthcare industry where it is being utilized for diagnostic procedures.

Similarly, metagenomics procedures are being adopted for reducing toxicity in the environment. The rising usage of metagenomics in clinical diagnostics and bioremediation is anticipated to boost the growth in the market during the forecast period.

Which is the dominant end-use industry in the market?

Demand for metagenomics remains high in pharmaceutical industries and academic and research Institutes

In terms of end use, pharmaceutical, and academic & research segments are likely to generate the maximum revenue through 2033.

With the rising prevalence of multiple chronic diseases, pharmaceutical companies and government health organizations are investing in the development of innovative drugs. Thus, the application of metagenomics is expected to increase over the forecast period. Similarly, various research activities are being conducted across educational institutions for studying and elucidating the genetic structure of microbial communities.

Start-ups develop Automation enabled Metagenomics Solution

The start-ups have developed metagenomic screening tools to aid bio-discovery. The platform developed by them enables the expression of genes from diverse sources. The combination of automation, computation, and high-throughput screening assists in capturing a large variety of proteins.

Metagenomi: The start-up utilizes metagenomics to discover next-generation gene-editing tools. The discovery engine developed by Metagenomi uses AI-backed cloud computing to find natural enzyme systems in microbial environments. It finds compact nucleases that enable the delivery of AAV vectors. The search solution developed by them is mainly for therapeutic solutions. In January 2023, Metagenomi closed oversubscribed Series B funding standing at US$ 275 million to lead therapeutic programs into clinical development.

Key Manufacturers sign Strategic Collaborations to Enhance Research Prowess

The key players look to form profitable strategic collaborations. This would enable them to develop a combined framework of technologies that can increase the yield and find promising drugs based on human omics insights. In October 2022, Illumina launched a strategic collaboration with AstraZeneca for accelerating drug target discovery.

Key developments in the market are:

  • In November 2022, Illumina boosted its genomic innovation in the United Arab Emirates through a new state-of-the-art solutions center.
  • In November 2022, PerkinElmer helped accelerate gene therapy research with industry-first ready-to-use viral vector assays.

Dominant players in the market are:

Company Illumina
Description Illumina has always worked towards improving human health by unlocking the power of the genome. By delivering breakthroughs in genomics, the company empowers visionaries around the globe to uncover answers. The company has enabled researchers and clinicians to turn big dreams into impactful genomic discoveries that improve lives. Inspired by deep customer insights, Illumina leads the way in delivering purposeful advances that address critical needs and enable support researchers.
Company PerkinElmer
Description PerkinElmer is a global provider of end-to-end solutions which help scientists, researchers, and clinicians better diagnose disease. With more than an 8-decade legacy of advancing science, the team of more than 16,000 collaborates with healthcare, academic, commercial, and government customers. The company reported revenues of more than US$ 5 billion in 2021 and is currently serving in more than 190 countries. It is a component of the prestigious S&P 500 index.
Company Trivitron Healthcare Pvt. Ltd.
Description Being a part of this niche for more than two and a half decades, the journey of Trivitron as a medical technology presents a fascinating thread of inspiration. The company has been marketing its products to hospitals, healthcare providers, independent clinics, and laboratories. As a pioneer in this field, the company constantly pursues technological innovation to offer superior benefits at a lower cost. The company believes in delivering quality healthcare as a fundamental right.

Other prominent companies profiled: are Qiagen N.V., and Thermo Fisher Scientific.

Metagenomics Market Segmentation

By Product Type:

  • Library Preparation Kits
  • Sample Extraction Kits
  • Metagenomic Sequencing Kits

By Application:

  • Microbial Diversity
  • Bioremediation and Degradation
  • Bio Surfactants and Antibiotics Production
  • Clinical Diagnostics
  • Others

By End User:

  • Pharmaceutical Industries
  • Research Laboratories
  • Biotechnology Companies
  • Pathology Laboratories
  • Academic and Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • Commonwealth of Independent States and Russia
  • Japan
  • Asia Pacific Excluding Japan
  • The Middle East and Africa

Frequently Asked Questions

How Big is the Metagenomics Market?

The market is valued at US$ 202.9 million in 2023.

Which are the 3 Key Companies in the Metagenomics Market?

The top 3 companies leading in the market are Illumina, Thermo Fisher Scientific, and QIAGEN.

Which Industry is the Key Consumer of the Metagenomics Market?

The life sciences industry is the primary consumer of the metagenomics market.

How Big Will the Metagenomics Market by 2033?

The market is estimated to reach US$ 394.2 million by 2033.

What is the Metagenomics Market CAGR from 2023 to 2033?

The metagenomics market is expected to expand at a CAGR of 6.9% by 2033.

Table of Content

1. Executive Summary | Metagenomics Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Library Preparation Kits

        5.3.2. Sample Extraction Kits

        5.3.3. Sequencing Kits

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ million) Analysis By Application, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Microbial Diversity

        6.3.2. Bioremediation and Degradation

        6.3.3. Bio Surfactants and Antibiotics Production

        6.3.4. Clinical Diagnostics

        6.3.5. Others

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ million) Analysis By End User, 2017 to 2022

    7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2023 to 2033

        7.3.1. Pharmaceutical Industries

        7.3.2. Research Laboratories

        7.3.3. Biotechnology Companies

        7.3.4. Pathology Laboratories

        7.3.5. Academic and Research Institutes

        7.3.6. Others

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022

    8.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. CIS & Russia

        8.3.5. Asia-Pacific excluding Japan (APEJ)

        8.3.6. Japan

        8.3.7. Middle East and Africa (MEA)

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. United States of America

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Application

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Application

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Application

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Application

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. EU-4

            11.2.1.2. United Kingdom

            11.2.1.3. BENELUX

            11.2.1.4. Rest of Europe

        11.2.2. By Product Type

        11.2.3. By Application

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Application

        11.3.4. By End User

    11.4. Key Takeaways

12. CIS & Russia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

        12.2.2. By Product Type

        12.2.3. By Application

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Application

        12.3.4. By End User

    12.4. Key Takeaways

13. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. India

            13.2.1.3. ASEAN

            13.2.1.4. South Korea

            13.2.1.5. Rest of APEJ

        13.2.2. By Product Type

        13.2.3. By Application

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Application

        13.3.4. By End User

    13.4. Key Takeaways

14. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

        14.2.2. By Product Type

        14.2.3. By Application

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Application

        14.3.4. By End User

    14.4. Key Takeaways

15. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Rest of MEA

        15.2.2. By Product Type

        15.2.3. By Application

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Application

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. United States of America

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product Type

            16.1.2.2. By Application

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product Type

            16.2.2.2. By Application

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product Type

            16.3.2.2. By Application

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product Type

            16.4.2.2. By Application

            16.4.2.3. By End User

    16.5. EU-4

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product Type

            16.5.2.2. By Application

            16.5.2.3. By End User

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product Type

            16.6.2.2. By Application

            16.6.2.3. By End User

    16.7. BENELUX

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product Type

            16.7.2.2. By Application

            16.7.2.3. By End User

    16.8. CIS & Russia

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product Type

            16.8.2.2. By Application

            16.8.2.3. By End User

    16.9. China

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product Type

            16.9.2.2. By Application

            16.9.2.3. By End User

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product Type

            16.10.2.2. By Application

            16.10.2.3. By End User

    16.11. ASIAN

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product Type

            16.11.2.2. By Application

            16.11.2.3. By End User

    16.12. South Korea

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product Type

            16.12.2.2. By Application

            16.12.2.3. By End User

    16.13. Japan

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product Type

            16.13.2.2. By Application

            16.13.2.3. By End User

    16.14. GCC Countries

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product Type

            16.14.2.2. By Application

            16.14.2.3. By End User

    16.15. South Africa

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product Type

            16.15.2.2. By Application

            16.15.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Application

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Illumina Inc

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Perkin Elmer Inc.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Trivitron Healthcare Pvt. Ltd.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Qiagen N.V.

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Thermo Fisher Scientific

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Symbio Scientific Pvt. Ltd.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Infobio

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Bio-Rad Laboratories

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Merck KgaA

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Promega Corporation

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Synthetic Genomics Market

Published : January 2023

Healthcare

Genomics Market

Published : December 2022

Explore Healthcare Insights

View Reports